The Valley Desk

NCT00230217 · Interventional trial

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Overall registry status Completed

Phase 4

Conditions Hyperuricemia, Tumor Lysis Syndrome, Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov